• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与临床候选药物CK0238273结合的HsEg5晶体结构揭示了其抑制机制、效力和特异性。

Crystal structure of HsEg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity.

作者信息

Zhang Bin, Liu Ji-Feng, Xu Yingwu, Ng Shi-Chung

机构信息

ArQule Biomedical Institute, ArQule Incorporated, 333 Providence Highway, Norwood, MA 02062, USA.

出版信息

Biochem Biophys Res Commun. 2008 Aug 8;372(4):565-70. doi: 10.1016/j.bbrc.2008.05.074. Epub 2008 May 27.

DOI:10.1016/j.bbrc.2008.05.074
PMID:18503753
Abstract

HsEg5 is an important mitotic kinesin responsible for bipolar spindle formation at early mitosis. A rich body of evidence shows that inhibition of HsEg5 can result in mitotic arrest followed by cellular apoptosis. Recently identified HsEg5 inhibitor, CK0238273, exhibits potent antitumor activity and is currently in clinical trial. Here we report the cocrystal structure of the motor domain of HsEg5 in complex with CK0238273 at a 2.15 A resolution. Compared to the previously published HsEg5-Monastrol complex structure, CK0238273 shares the same induced-fit pocket with similar allosteric inhibitory mechanism. However, CK0238273 shows better fitting to the binding pocket with 65% increase of hydrophobic interaction area than that of Monastrol. Some unique hydrophilic interactions were also observed mostly between the phenyl ring and 8-chloro on quinazolinone of CK0238273 with ARG221 and GLY217. We believe that the combination of these interactions defines the superior potency and specificity of CK0238273.

摘要

HsEg5是一种重要的有丝分裂驱动蛋白,负责在有丝分裂早期形成双极纺锤体。大量证据表明,抑制HsEg5会导致有丝分裂停滞,随后细胞凋亡。最近鉴定出的HsEg5抑制剂CK0238273具有强大的抗肿瘤活性,目前正处于临床试验阶段。在此,我们报告了HsEg5运动结构域与CK0238273复合物的共晶体结构,分辨率为2.15埃。与先前发表的HsEg5-莫那可林复合物结构相比,CK0238273具有相同的诱导契合口袋,且变构抑制机制相似。然而,CK0238273与结合口袋的契合度更好,疏水相互作用面积比莫那可林增加了65%。还观察到一些独特的亲水相互作用,主要发生在CK0238273喹唑啉酮上的苯环和8-氯与ARG221和GLY217之间。我们认为,这些相互作用的组合决定了CK0238273的卓越效力和特异性。

相似文献

1
Crystal structure of HsEg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity.与临床候选药物CK0238273结合的HsEg5晶体结构揭示了其抑制机制、效力和特异性。
Biochem Biophys Res Commun. 2008 Aug 8;372(4):565-70. doi: 10.1016/j.bbrc.2008.05.074. Epub 2008 May 27.
2
Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.鉴定S-三苯甲基-L-半胱氨酸(一种有丝分裂驱动蛋白Eg5的新型强效抑制剂)的蛋白结合区域。
Biochemistry. 2004 Oct 19;43(41):13072-82. doi: 10.1021/bi049264e.
3
Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.环 5 定向化合物抑制嵌合驱动蛋白-5 马达:对保守变构机制的影响。
J Biol Chem. 2011 Feb 25;286(8):6201-10. doi: 10.1074/jbc.M110.154989. Epub 2010 Dec 2.
4
Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.有丝分裂抑制剂monastrol与人类驱动蛋白Eg5的相互作用。
Biochemistry. 2003 Jan 21;42(2):338-49. doi: 10.1021/bi026716j.
5
Inhibition of a mitotic motor protein: where, how, and conformational consequences.有丝分裂运动蛋白的抑制:作用位置、方式及构象后果
J Mol Biol. 2004 Jan 9;335(2):547-54. doi: 10.1016/j.jmb.2003.10.074.
6
NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.NSC 622124 通过与保守的微管结合位点相互作用抑制人 Eg5 和其他动力蛋白。
Biochemistry. 2009 Mar 3;48(8):1754-62. doi: 10.1021/bi801291q.
7
Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.在存在二磷酸腺苷(ADP)和三磷酸腺苷(ATP)的情况下,莫那可林与驱动蛋白样蛋白5(Eg5)变构相互作用的差异:傅里叶变换红外光谱(FT-IR)差异研究
Biochemistry. 2004 Aug 10;43(31):9939-49. doi: 10.1021/bi048982y.
8
Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.二氢嘧啶类抑制 Eg5 的结构基础:抗有丝分裂抑制剂恩曲他滨、二甲烯氟苯及氟他胺的立体选择性。
J Med Chem. 2010 Aug 12;53(15):5676-83. doi: 10.1021/jm100421n.
9
Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.有证据表明,莫那可林(monastrol)是有丝分裂驱动蛋白Eg5的变构抑制剂。
Chem Biol. 2002 Sep;9(9):989-96. doi: 10.1016/s1074-5521(02)00212-0.
10
Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.莫那可林对人KSP的抑制机制:动力学分析及离子强度对KSP抑制作用的见解
Biochemistry. 2004 Dec 7;43(48):15258-66. doi: 10.1021/bi048282t.

引用本文的文献

1
RAB11A and RAB11B control mitotic spindle function in intestinal epithelial progenitor cells.RAB11A 和 RAB11B 控制肠道上皮祖细胞有丝分裂纺锤体功能。
EMBO Rep. 2023 Sep 6;24(9):e56240. doi: 10.15252/embr.202256240. Epub 2023 Jul 10.
2
Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands.基于异长春花碱衍生配体的 Ru、Os、Rh 和 Ir 半三明治配合物的金属依赖性细胞毒性和驱动蛋白纺锤体蛋白抑制活性。
Inorg Chem. 2020 Oct 19;59(20):14879-14890. doi: 10.1021/acs.inorgchem.0c00957. Epub 2020 Oct 1.
3
Structural and Thermodynamic Basis of the Enhanced Interaction between Kinesin Spindle Protein Eg5 and STLC-type Inhibitors.
驱动蛋白纺锤体蛋白Eg5与STLC型抑制剂之间增强相互作用的结构和热力学基础
ACS Omega. 2018 Sep 28;3(9):12284-12294. doi: 10.1021/acsomega.8b00778. eCollection 2018 Sep 30.
4
Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy.癌症治疗中极间有丝分裂驱动蛋白抑制剂的最新研究成果与未来方向
Future Med Chem. 2016;8(4):463-89. doi: 10.4155/fmc.16.5. Epub 2016 Mar 15.
5
Force generation by kinesin and myosin cytoskeletal motor proteins.肌球蛋白和驱动蛋白细胞骨架马达蛋白的力产生。
J Cell Sci. 2013 Jan 1;126(Pt 1):9-19. doi: 10.1242/jcs.103911. Epub 2013 Mar 13.
6
The structure of the ternary Eg5-ADP-ispinesib complex.三元 Eg5-ADP-艾司匹替尼复合物的结构。
Acta Crystallogr D Biol Crystallogr. 2012 Oct;68(Pt 10):1311-9. doi: 10.1107/S0907444912027965. Epub 2012 Sep 13.
7
Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.环 5 定向化合物抑制嵌合驱动蛋白-5 马达:对保守变构机制的影响。
J Biol Chem. 2011 Feb 25;286(8):6201-10. doi: 10.1074/jbc.M110.154989. Epub 2010 Dec 2.
8
Allosteric drug discrimination is coupled to mechanochemical changes in the kinesin-5 motor core.变构药物识别与驱动蛋白-5运动核心的机械化学变化相关联。
J Biol Chem. 2010 Jun 11;285(24):18650-61. doi: 10.1074/jbc.M109.092072. Epub 2010 Mar 18.